M

Medapp SA
WSE:MDA

Watchlist Manager
Medapp SA
WSE:MDA
Watchlist
Price: 0.18 PLN -2.7% Market Closed
Market Cap: 45m PLN
Have any thoughts about
Medapp SA?
Write Note

Intrinsic Value

The intrinsic value of one MDA stock under the Base Case scenario is 0.1 PLN. Compared to the current market price of 0.18 PLN, Medapp SA is Overvalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MDA Intrinsic Value
0.1 PLN
Overvaluation 44%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation Backtest
Medapp SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MDA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MDA?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Medapp SA

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Medapp SA

Provide an overview of the primary business activities
of Medapp SA.

What unique competitive advantages
does Medapp SA hold over its rivals?

What risks and challenges
does Medapp SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medapp SA.

Provide P/S
for Medapp SA.

Provide P/E
for Medapp SA.

Provide P/OCF
for Medapp SA.

Provide P/FCFE
for Medapp SA.

Provide P/B
for Medapp SA.

Provide EV/S
for Medapp SA.

Provide EV/GP
for Medapp SA.

Provide EV/EBITDA
for Medapp SA.

Provide EV/EBIT
for Medapp SA.

Provide EV/OCF
for Medapp SA.

Provide EV/FCFF
for Medapp SA.

Provide EV/IC
for Medapp SA.

What are the Revenue projections
for Medapp SA?

How accurate were the past Revenue estimates
for Medapp SA?

What are the Net Income projections
for Medapp SA?

How accurate were the past Net Income estimates
for Medapp SA?

What are the EPS projections
for Medapp SA?

How accurate were the past EPS estimates
for Medapp SA?

What are the EBIT projections
for Medapp SA?

How accurate were the past EBIT estimates
for Medapp SA?

Compare the revenue forecasts
for Medapp SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medapp SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medapp SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medapp SA compared to its peers.

Compare the P/E ratios
of Medapp SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Medapp SA with its peers.

Analyze the financial leverage
of Medapp SA compared to its main competitors.

Show all profitability ratios
for Medapp SA.

Provide ROE
for Medapp SA.

Provide ROA
for Medapp SA.

Provide ROIC
for Medapp SA.

Provide ROCE
for Medapp SA.

Provide Gross Margin
for Medapp SA.

Provide Operating Margin
for Medapp SA.

Provide Net Margin
for Medapp SA.

Provide FCF Margin
for Medapp SA.

Show all solvency ratios
for Medapp SA.

Provide D/E Ratio
for Medapp SA.

Provide D/A Ratio
for Medapp SA.

Provide Interest Coverage Ratio
for Medapp SA.

Provide Altman Z-Score Ratio
for Medapp SA.

Provide Quick Ratio
for Medapp SA.

Provide Current Ratio
for Medapp SA.

Provide Cash Ratio
for Medapp SA.

What is the historical Revenue growth
over the last 5 years for Medapp SA?

What is the historical Net Income growth
over the last 5 years for Medapp SA?

What is the current Free Cash Flow
of Medapp SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medapp SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medapp SA

Current Assets 10.4m
Cash & Short-Term Investments 168k
Receivables 3m
Other Current Assets 7.2m
Non-Current Assets 25.8m
Long-Term Investments 1.6m
PP&E 60k
Intangibles 24.1m
Other Non-Current Assets 40k
Current Liabilities 7.4m
Accounts Payable 2m
Short-Term Debt 1.9m
Other Current Liabilities 3.4m
Non-Current Liabilities 4.1m
Long-Term Debt 20k
Other Non-Current Liabilities 4m
Efficiency

Earnings Waterfall
Medapp SA

Revenue
4.7m PLN
Cost of Revenue
-666k PLN
Gross Profit
4m PLN
Operating Expenses
-6.1m PLN
Operating Income
-2.1m PLN
Other Expenses
-367k PLN
Net Income
-2.4m PLN

Free Cash Flow Analysis
Medapp SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MDA Profitability Score
Profitability Due Diligence

Medapp SA's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative Operating Income
Positive 3-Year Average ROE
Positive 3-Year Average ROIC
37/100
Profitability
Score

Medapp SA's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

MDA Solvency Score
Solvency Due Diligence

Medapp SA's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
51/100
Solvency
Score

Medapp SA's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MDA Price Targets Summary
Medapp SA

There are no price targets for MDA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MDA?

Click here to dive deeper.

Dividends

Medapp SA
does not pay dividends
Shareholder Yield

Current shareholder yield for MDA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Medapp SA

Country

Poland

Industry

Health Care

Market Cap

45m PLN

Dividend Yield

0%

Description

MedApp SA engages in the provision of mobile marketing solutions in the field of medicine. The company is headquartered in Krakow, Woj. Malopolskie. The company went IPO on 2011-10-19. The firm provides a software application, named Carna Life, which is used in telemedicine sector. Carna Life serves as communication channel between doctors and patient. Carna Life is a telemedicine system that enables patients to upload test results and receive doctor's interpretation. The application operates in online (upload and download of data) and offline (review of data) mode. Carna Life provides statistics, graphic visualizations and tables with interpreted data. The firm is controlled by Moonrock Enterprise SA.

Contact

WOJ. MALOPOLSKIE
Krakow
Armii Krajowej 25
medapp.pl

IPO

2011-10-19

Employees

-

Officers

See Also

Discover More
What is the Intrinsic Value of one MDA stock?

The intrinsic value of one MDA stock under the Base Case scenario is 0.1 PLN.

Is MDA stock undervalued or overvalued?

Compared to the current market price of 0.18 PLN, Medapp SA is Overvalued by 44%.

Back to Top